menu search

Diffusion pharmaceuticals (dffn) stock: 1-for-50 reverse stock split announced

Diffusion pharmaceuticals Inc. (NASDAQ: DFFN) announced it will effect a 1-for-50 reverse stock split o...

April 18, 2022, 8:28 pm

Johnson & johnson set to report earnings on tuesday morning

#Johnson&Johnson #Johnson&Johnsonstock # pharmaceutical company Johnson & Johnson is set to release its...

April 18, 2022, 7:22 pm

Why biocryst pharmaceuticals stock sank today

Another analyst gets notably less enthusiastic about the company's prospects....

April 18, 2022, 5:40 pm

Ibb: healthcare dashboard for april

pharmaceuticals and biotechnology still are attractive regarding value and quality. Other subsectors ar...

April 18, 2022, 1:58 pm

Edesa biotech: leader in developing treatments for covid-19 and acd

Edesa is one of 4 pharmaceutical companies that received a grant from the Canadian government to develo...

April 18, 2022, 1:53 pm

Diffusion pharmaceuticals' 50-for-1 stock split will go into effect tomorrow

Diffusion pharmaceuticals Inc (NASDAQ: DFFN) will effect a 1-for-50 reverse stock split of its commo...

April 18, 2022, 10:52 am

Why diffusion pharmaceuticals shares are falling

Diffusion pharmaceuticals Inc (NASDAQ: DFFN) shares are trading lower by 20.83% at $0.21 after the comp...

April 18, 2022, 9:48 am

Tesla earnings follow musk's take-it-or-leave-it twitter bid

First-quarter earnings season starts to heat up this week. Among the notable names on the earnings calendar are electric carmaker Tesla (TSLA, $986.01...

April 18, 2022, 6:33 am

3 reasons vertex pharmaceuticals is a top stock to buy now

A research engine fueled by a $7.6 billion-per-year franchise is cranking out one hit after another....

April 16, 2022, 6:18 am

Alkermes: turning the tides towards profitability

Alkermes is a publicly-traded company that offers biopharmaceutical products and technology. The compan...

April 16, 2022, 1:41 am

Should you invest in the spdr s&p pharmaceuticals etf (xph)?

Sector ETF report for XPH...

April 15, 2022, 7:32 am

Why biochryst pharmaceuticals' stock jumped 14.7% this week

Investors returned to the stock after last week's sell-off....

April 14, 2022, 6:07 pm

Citius pharmaceuticals to present at the noblecon18 investor conference on april 20, 2022

CRANFORD, N.J. , April 14, 2022 /PRNewswire/ -- Citius pharmaceuticals, Inc. ("Citius" or the "Company"...

April 14, 2022, 9:25 am

Biohaven pharmaceutical: recent growth will continue

Biohaven pharmaceutical has a significant portfolio of innovative product candidates across neurologica...

April 14, 2022, 4:23 am

Knight therapeutics - a marshmallow test of patience

Knight Therapeutics Inc. ( TSX:GUD , Financial) is a specialty pharmaceutical company headquartered in ...

April 13, 2022, 3:01 pm

Gilead sciences: the most undervalued pharmaceutical company

According to my DCF analysis, GILD stock has a potential upside of almost 100%. After 7 years of stalemate, Gilead Sciences may be ready to reverse it...

April 13, 2022, 2:55 pm

Late-stage biopharmaceutical sierra oncology announces acquisition by gsk

Sierra Oncology (NASDAQ: SRRA) shares traded significantly higher after announcing the acquisition by GlaxoSmithKline PLC (LON: GSK) for $55 a share i...

April 13, 2022, 1:49 pm

Antares pharma stock rockets after halozyme buyout deal for a near-50% premium

Shares of Antares Pharma Inc. ATRS, -0.27% rocketed 46.3% in premarket trading Wednesday toward a two-decade high, after the specialty ...

April 13, 2022, 6:12 am

Glaxosmithkline to buy sierra oncology for $1.9 billion

pharmaceutical giant GlaxoSmithKline PLC said Wednesday that it is buying bio...

April 13, 2022, 2:36 am

Gsk to buy sierra oncology for $1.9 billion

Britain's GlaxoSmithKline has agreed to buy California-based biopharmaceutical company Sierra Oncology ...

April 13, 2022, 2:23 am


Search within

Pages Search Results: